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Introduction 
Talc pleurodesis is one of the established methods used in 
the treatment of pneumothorax (1). The present report 
describes a case of a patient who developed an apical 
pleural mass following this treatment. 
Case Report 
A 24-year-old woman presented in April 1992 with a 2-day 
history of chest pain and dyspnoea. She smoked but had no 
previous history of chest disease. A chest X-ray revealed a 
large right-sided pneumothorax. This was initially treated 
by tube thoracostomy. Although the lung expanded, the air 
leak continued, so after 13 days, a talc pleurodesis was 
carried out. 
Under general anaesthesia, a thoracoscope was inserted 
through the fifth intercostal space in the right anterior 
axillary line. No structural damage to the right lung could 
be detected; therefore, talc pleurodesis was thought to be 
the most appropriate form of treatment. Approximately 1 g 
of an iodized talc was insufflated through a previously 
created stab incision. The procedure was completed with 
the insertion of a single 28 French intercostal chest drain. 
The patient was discharged home 3 days later. She pre- 
sented next in October 1993 with abdominal and left-sided 
chest pain (on the other side from the pleurodesis). This 
settled without a clear diagnosis being made. A chest X-ray 
showed an opacity at the right apex. She was seen again in 
the outpatient clinic in November 1994 with a variety of 
symptoms including dyspnoea, dizziness and lethargy, 
which were thought to be stress related. However, a further 
chest X-ray showed an apparent increase in size of the right 
apical opacity (Plate 1). A computerized tomographic (CT) 
scan showed this to be a well-defined, posteriorly placed, 
thick-walled encysted effusion with a maximum diameter of 
about 4-5 cm (Plate 2). The attenuation value of the fluid 
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PLATE 1. P. A. Chest taken in September 1994, showing a 
large pleural-based right apical mass. 
PLATE 2. Chest CT scan (Patient prone) taken in Decem- 
ber 1994, showing the right apical encysted effusion with 
biopsy needle in situ. 
was 16 Hounsfield’s units (HU), and of the dense capsule, 
140 HU. A trucut biopsy of the wall was obtained, but 
unfortunately the patient was considerably upset by the 
procedure, despite intravenous Midazolam sedation, so it 
was not possible to aspirate the fluid. 
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The biopsy showed fibrous tissue containing birefringent 
needle-shaped crystals that excited a foreign body giant cell 
reaction. There was no evidence of malignancy. The biopsy 
was interpreted as talc granuloma of the pleura. A further 
chest X-ray in March 1995 was unchanged. 
Discussion 
Talc pleurodesis is a widely used procedure in the treatment 
of pneumothorax (1) with a low recurrence rate (24). 
X-ray changes following the procedure include obliteration 
of the costophrenic angle (2) small pleural patches or 
occasionally pleural thickening with calcification (5,6). 
Some series, however, report no examples of pleural thick- 
ening (2,3). 
The present patient is of interest in that she developed an 
apparent apical mass which increased in size between 1993 
and 1994. On CT scan, this was shown to be a thick-walled 
encysted effusion. 
The mechanism of action of talc is not certain, but may 
be, in part, an inflammatory reaction and may also act by 
interfering with the normal production of fluid by the 
visceral mesothelium (4). 
The fibrosis caused by iodized talc may be related to the 
amount used (4) but only 1 g was used in this case, which is 
thought to be a very safe dose (3,4). 
The major concern related to talc pleurodesis is 
that it may cause pleural malignancy. An increased inci- 
dence of carcinoma of the lung (and one case of fibro- 
sarcoma of the pleura) was reported in a follow-up study 
of talc workers (7). However, the talc contained tremolite 
and anthophyllite which may have been the carcinogenic 
agents. 
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To date, there is no report of malignancy following talc 
pleurodesis. There are several choices in the management of 
spontaneous pneumothorax with persistent air leak follow- 
ing initial chest intubation. Video-assisted thoracoscopic 
resection of lung bullae and blebs combined or not with a 
partial pleurectomy or mechanical pleural abrasion is 
becoming a preferred option. Talc pleurodesis is the least 
invasive intervention possible. Apparent complication in 
the form of talc granuloma is practically unknown. 
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Introduction 
Rhabdomyolysis is most commonly caused by muscular 
crush injuries, alcohol myopathy, and seizures. Bacterial 
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and viral infections account for only 5% of the patients with 
rhabdomyolysis (1). Although approximately 92 500 cases 
of community-acquired pneumonia occur annually in the 
U.S.A. and account for 2.8% of hospital admissions (2) 
rhabdomyolysis is rarely identified with pneumonia. How- 
ever, it has recently been recognised that rhabdomyolysis, 
in the setting of pulmonary infection with Legionella pneu- 
mophila, has important prognostic implications (3). The 
significance of rhabdomyolysis in other bacterial infections 
of the lung has not been investigated. The present report 
